InvestSMART

EVE Health Group Limited (ASX: EVE) - Announcements

- Current share price for EVE : $0.015

ASX company news and announcements for EVE Health Group Limited (EVE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EVE Health Group Limited (EVE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EVE Health Group Limited (EVE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EVE Health Group Limited (EVE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Eve Commences Distribution of Dyspro 22 Sep 2025 8:21AM $0.029 $0.015 fallen by 48.28%
$5 Appointment of Dr Fiona Cousins to Scientific Advisory Board 15 Sep 2025 8:23AM $0.026 $0.015 fallen by 42.31%
$5 Date of AGM and Closing Date for Director Nominations 11 Sep 2025 6:04PM $0.028 $0.015 fallen by 46.43%
$5 Appendix 4G and Corporate Governance Statement 29 Aug 2025 4:09PM $0.032 $0.015 fallen by 53.13%
$5 Annual Report to shareholders 29 Aug 2025 4:08PM $0.032 $0.015 fallen by 53.13%
$5 Appendix 4E 29 Aug 2025 4:08PM $0.032 $0.015 fallen by 53.13%
$5 Appendix 4E 29 Aug 2025 4:08PM $0.032 $0.015 fallen by 53.13%
$5 EVE Submits First Commercial Purchase Order for Libbo 19 Aug 2025 8:50AM $0.032 $0.015 fallen by 53.13%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 9:21AM $0.034 $0.015 fallen by 55.88%
$5 Aust Regulatory Path Cleared for ED & Dysmenorrhea Products 21 Jul 2025 9:27AM $0.030 $0.015 fallen by 50%
$5 EVE Submits First Commercial Purchase Order for Dyspro 7 Jul 2025 8:49AM $0.035 $0.015 fallen by 57.14%
$5 Application for quotation of securities - EVE 26 Jun 2025 12:45PM $0.029 $0.015 fallen by 48.28%
$5 Completion of Share Purchase Plan 26 Jun 2025 12:44PM $0.029 $0.015 fallen by 48.28%
$5 Change of Director's Interest Notice 17 Jun 2025 1:41PM $0.032 $0.015 fallen by 53.13%
$5 Prescribing Agreement for ED and Dysmenorrhea Products 16 Jun 2025 8:38AM $0.035 $0.015 fallen by 57.14%
$5 EVE Investor Webinar 13 Jun 2025 11:23AM $0.036 $0.015 fallen by 58.33%
$5 Ceasing to be a substantial holder 12 Jun 2025 5:14PM $0.035 $0.015 fallen by 57.14%
$5 Becoming a substantial holder 12 Jun 2025 5:14PM $0.035 $0.015 fallen by 57.14%
$5 Initial Director's Interest Notice 12 Jun 2025 5:11PM $0.035 $0.015 fallen by 57.14%
$5 Final Director's Interest Notice 12 Jun 2025 5:11PM $0.035 $0.015 fallen by 57.14%
$5 EVE Completes Nextract Acquisition 12 Jun 2025 9:47AM $0.040 $0.015 fallen by 62.50%
$5 Application for quotation of securities - EVE 12 Jun 2025 9:41AM $0.040 $0.015 fallen by 62.50%
$5 Prospectus 11 Jun 2025 3:20PM $0.040 $0.015 fallen by 62.50%
$5 Change of Director's Interest Notice x 2 11 Jun 2025 11:19AM $0.038 $0.015 fallen by 60.53%
$5 Completion of Share Consolidation 11 Jun 2025 10:05AM $0.040 $0.015 fallen by 62.50%

76 - 100 of 723 results

Page 4 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.